Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics of tigecycline in critically ill patients
ChiCTR1800019238Phase 4Recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Aug 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tigecycline in Infection (2 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Plasma concentration of tigecycline. Started Aug 2018; status: recruiting.
02
Drugs
tigecycline
03
Conditions
Infection
Beyond the preview
Go deeper on ChiCTR1800019238.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019238.